Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...

AI guarding AI, alerts firing every second—but one thing never seems to change: People are still the weak point.

– In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF <50% – – On track to deliver full 12 ...

Statutory body said its work has widened to multiple IT systems, and could even look at potential Post Office miscarriages of ...

The “AI slop” problem has generated a fair amount of cultural buzz and media attention over the past few years as the use of ...

Developers are navigating confusing gaps between expectation and reality. So are the rest of us. Depending who you ask, AI-powered coding is either giving software developers an unprecedented ...